Buscar
Mostrando ítems 1-6 de 6
Congenital muscular dystrophy. Part II: a review of pathogenesis and therapeutic perspectives
(Academia Brasileira de Neurologia - ABNEURO, 2009)
The congenital muscular dystrophies (CMDs) are a group of genetically and clinically heterogeneous hereditary myopathies with preferentially autosomal recessive inheritance, that are characterized by congenital hypotonia, ...
Congenital muscular dystrophy. Part I: a review of phenotypical and diagnostic aspects
(Academia Brasileira de Neurologia - ABNEURO, 2009)
The congenital muscular dystrophies (CMDs) are a group of genetically and clinically heterogeneous hereditary myopathies with preferentially autosomal recessive inheritance, that are characterized by congenital hypotonia, ...
Trastornos plaquetarios primarios en la especie humana: Aspectos biomédicos: biología, patobiología y bioclínica
(Sociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la Salud, 2007-09-01)
Identificación de interacciones proteicas de ADAMTS19 en un contexto ovárico
(Universidad del RosarioMaestría en Ciencias con Énfasis en Genética HumanaFacultad de medicina, 2017)
ADAMTS proteins (disintegrins and metalloproteinases with thrombospondin motifs) have been associated with various biological processes including follicular development and ovulation. Some members are considered orphan ...
Encapsulación de puntos de carbono en un hidrogel basado en alginato: Prueba de concepto de liberación controlada de fármacos
Drug delivery systems seek to deliver a therapeutic amount of a molecule or compound with a biological or biomedical purpose to the body. These systems are classified into traditional, modified and controlled release. ...